Loading...
*  substance withdrawal syndrome
... Summary. Summary: Physiological and psychological symptoms associated with withdrawal from the ... The marijuana withdrawal syndrome: diagnosis and treatment. Margaret Haney. New York State Psychiatric Institute, College of ... Modeling withdrawal syndrome in zebrafish. Jonathan Cachat. Department of Pharmacology and Neuroscience Program, Tulane ... Modeling withdrawal syndrome in zebrafish. Jonathan Cachat. Department of Pharmacology and Neuroscience Program, Tulane ...
  https://www.labome.org/topics/diseases/disorders/substance/substance-withdrawal-syndrome-8421.html
*  Substance Withdrawal Syndrome
... At find-more-books.com you can find used, antique and new books, COMPARE results and immediately ... General Substance-Withdrawal-Syndrome~~Janet-P-Rees Nova Science Publishers, Incorporated Substance Withdrawal Syndrome refers ... Substance Withdrawal Syndrome refers to the physiological and psychological symptoms associated with withdrawal from the use of ... Substance Withdrawal Syndrome refers to the physiological and psychological symptoms associated with withdrawal from the use of ...
  https://www.find-more-books.com/book/isbn/9781606929513.html
*  DMOZ - Health: Specific Substances: Alcoholic Beverages: Detriments: Alcohol Withdrawal Syndrome
Alcohol Withdrawal Syndrome Information about the syndrome, and what doctors, family, and friends can do to help. Provided by ... "Health ... Alcohol Withdrawal Syndrome" search on: AOL - Ask - Bing - DuckDuckGo - Gigablast - Google - ixquick - Yahoo - ... Alcohol Withdrawal Syndrome Information primarily for health professionals, provided by the National Institute on Alcohol Abuse ... MedlinePlus Medical Encyclopedia: Alcohol Withdrawal Overview, including definition, causes, incidence, risk factors, symptoms ...
  http://dmoztools.net/Health/Specific_Substances/Alcoholic_Beverages/Detriments/Alcohol_Withdrawal_Syndrome/
*  Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy - Full Text View - ClinicalTrials...
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Citalopram. ... Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy. The safety and scientific ... Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy- a Double-Blind Placebo-Controlled ... Recent studies have established the reliability, validity and time course of the cannabis withdrawal syndrome. This study will ...
  https://clinicaltrials.gov/ct2/show/NCT00598052?recr=Open&cond=%22Marijuana+Abuse%22&rank=6
*  Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) - Full Text View...
Substance Withdrawal Syndrome. Alcohol Withdrawal Delirium. Confusion. Neurobehavioral Manifestations. Neurologic ... Severe alcohol withdrawal syndrome (AWS) and alcohol withdrawal delirium (AWD) are frequent principal indication/s for ... Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD). This study has ... Alcohol Withdrawal Delirium Alcohol Withdrawal Associated Autonomic Hyperactivity Alcohol Withdrawal Hallucinosis Alcohol ...
  https://clinicaltrials.gov/show/NCT01362205
*  Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of beta-blocker withdrawal: a report from...
... and to determine how beta-blocker withdrawal the evening before DSE affects responses to dobutamine during DSE. DESIGN: Retros ... Substance Withdrawal Syndrome. Grant Support. ID/Acronym/Agency: M01-RR00425/RR/NCRR NIH HHS; N01-HV68161/HV/NHLBI NIH HHS; N01 ... Withdrawal of beta-blockers the evening before DSE may be inadequate time for elimination of beta-blocker effect, requiring the ... Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of beta-blocker withdrawal: a report from ...
  http://www.biomedsearch.com/nih/Dobutamine-pharmacodynamics-during-dobutamine-stress/12173796.html
*  Compound Report Card
Substance Withdrawal Syndrome. D013375. EFO:0005800. substance withdrawal syndrome. 1. ClinicalTrials. Carcinoma, Non-Small- ... Metabolic Syndrome. D024821. EFO:0000195. metabolic syndrome. 2. ClinicalTrials. Neonatal Sepsis. D000071074. HP:0040187. ...
  https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL45
*  MedGen for PubMed (Select 20633205) - MedGen - NCBI
Substance Withdrawal Syndrome. A substance-specific organic brain syndrome that follows the discontinuation of administration ... Substance-Related Disorder. A category of psychiatric disorders which include disorders related to the taking of a drug of ... Withdrawal. A social or emotional detachment, pathological retreat from objective reality, interpersonal contact and social ... Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense ...
  https://www.ncbi.nlm.nih.gov/medgen?LinkName=pubmed_medgen&from_uid=20633205
*  Caffeine: Read About Side Effects, Addiction, and Withdrawal
... withdrawal symptoms, the health effects of coffee, facts, symptoms, risks and side effects, pregnancy, and food sources (coffee ... substance-specific withdrawal syndrome; *substance often taken in larger amounts or over a longer period than expected; ... In order for a user of a substance to be considered dependent upon it, the substance needs to meet at least three of the above ... Irritable Bowel Syndrome (IBS). Irritable bowel syndrome (IBS) is a GI (gastrointestinal) disorder with signs and symptoms that ...
  https://www.medicinenet.com/caffeine/article.htm
*  Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients - Full Text View -...
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Methadone. ... Opioid Dependence Methadone Withdrawal Syndrome Drug: Lofexidine HCl Drug: Lofexidine-matching sugar pill Phase 1 ... baseline and daily assessments during methadone withdrawal phases (participant time in withdrawal will vary based on lofexidine ... baseline and daily assessments during methadone withdrawal phases (participant time in withdrawal will vary based on lofexidine ...
  https://clinicaltrials.gov/ct2/show/NCT01650649?recr=Open&intr=methadone&rank=20
*  Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal - Full Text View - ClinicalTrials.gov
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. ... We hypothesize that relative to a pre-quit baseline, post-quit nicotine withdrawal will result in increased activity to ... Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal. This study has been completed. ... To determine if bupropion and varenicline moderate patterns of brain activation during post-quit nicotine withdrawal. We ...
  https://clinicaltrials.gov/ct2/show/NCT00664404
*  Treatment of Alcohol Withdrawal in Hospital Patients - Full Text View - ClinicalTrials.gov
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Ethanol. Lorazepam ... Treatment of Alcohol Withdrawal in Hospital Patients. The safety and scientific validity of this study is the responsibility of ... Withdrawal Assessment Scores [ Time Frame: participants were followed for the duration of hospital stay, the median length of ... Alcohol withdrawal. Symptom-triggered therapy. Fixed-schedule therapy. CIWA-Ar. Lorazepam (drug). ...
  https://clinicaltrials.gov/show/NCT00249366
*  Nicotine Replacement Therapy in the Intensive Care Unit - Tabular View - ClinicalTrials.gov
Substance Withdrawal Syndrome. *Nicotine Replacement Therapy. Intervention ICMJE *Drug: Transdermal nicotine patch The test ... Lucidarme O, Seguin A, Daubin C, Ramakers M, Terzi N, Beck P, Charbonneau P, du Cheyron D. Nicotine withdrawal and agitation in ... The control product is a look-alike patch compared to the test product, containing no nicotine or other active substances. ... Other: Cutaneous patch, containing no active substances During the study period of thirty (30) days, the control product will ...
  https://clinicaltrials.gov/ct2/show/record/NCT01362959
*  Medications Development for the Treatment of Cannabis Related Disorders - Full Text View - ClinicalTrials.gov
Substance P. Recurrence. Substance Withdrawal Syndrome. Substance-Related Disorders. Disorders of Environmental Origin. Mental ... Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. ... Nicotine Withdrawal Marijuana Dependence Cannabis Dependence Nicotine Dependence Cannabis Abuse Drug: Placebo Aprepitant Drug: ... withdrawal symptom severity, measured on a 0 (not at all) to 3 (severe) scale [ Time Frame: collected on each study day ]. ...
  https://clinicaltrials.gov/ct2/show/NCT01204723?term=marijuana&recr=Closed&cntry1=NA%3AUS&rank=2
*  Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms - Full Text View - ClinicalTrials.gov
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. ... Nicotine Withdrawal Symptoms [ Time Frame: 5 to 35 minutes ]. The difference between lozenge use at the designated time-point ... The possible range of scores for the MNWS is between 0 and 28 with higher scores indicated greater withdrawal symptom severity. ... Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms. This study has been completed. ...
  https://clinicaltrials.gov/ct2/show/NCT01522963
*  Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 - Tabular View - ClinicalTrials.gov
Substance Withdrawal Syndrome. Intervention ICMJE Drug: Buprenorphine/naloxone. Study Arms Not Provided. ... report experiencing symptoms of opiate withdrawal, are currently physically dependent on opioids and are in need of medical ...
  https://clinicaltrials.gov/ct2/show/record/NCT00032968
*  Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction...
Substance Withdrawal Syndrome. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Immunosuppressive ... Thus, there is a need to identify predictive factors of successful drug withdrawal and to define the clinical and histological ... The main objective of this study is to establish the safety of attempting immunosuppressive (IS) drug withdrawal in stable ... Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction ...
  https://clinicaltrials.gov/ct2/show/NCT00647283
*  Nicotine Patch Trial in Syrian Primary Care Settings - Full Text View - ClinicalTrials.gov
Substance Withdrawal Syndrome. Depression. Additional relevant MeSH terms: Nicotine. Ganglionic Stimulants. Autonomic Agents. ... Withdrawal symptoms [ Time Frame: 7 weeks, 6 months, 12 months ]. Measured with the Withdrawal Symptoms List (Hughes et al., ... and coping with withdrawal symptoms and negative emotions. The final session occurs 14 days after quit day and emphasizes ...
  https://clinicaltrials.gov/ct2/show/NCT01085032
*  Observations on methadone withdrawal in 16 neonates.
... withdrawal of methadone can produce a withdrawal syndrome similar to heroin. After considerable experience with heroin ... Substance Withdrawal Syndrome*. Chemical. Reg. No./Substance: 76-99-3/Methadone From MEDLINE®/PubMed®, a database of the U.S. ... withdrawal of methadone can produce a withdrawal syndrome similar to heroin. After considerable experience with heroin ... withdrawal in neonates and in view of controversy and limited studies regarding methadone withdrawal, the study herein reported ...
  http://www.biomedsearch.com/nih/Observations-methadone-withdrawal-in-16/1120379.html
*  Running and addiction: precipitated withdrawal in a rat model of activity-based anorexia.
Substance Withdrawal Syndrome / physiopathology*. Grant Support. ID/Acronym/Agency: R01 DA004132-08/DA/NIDA NIH HHS; R01- ... Only minimal withdrawal symptoms were observed in inactive rats. These findings support the hypothesis that exercise-induced ... To assess the addictive potential of exercise, withdrawal symptoms following injections of 1.0 mg/kg naloxone were compared in ... Active food-restricted rats displayed the most withdrawal symptoms, followed by active rats given 24-hr access to food. ...
  http://www.biomedsearch.com/nih/Running-addiction-Precipitated-withdrawal-in/19634951.html
*  A Long-Term, Open-Label Study of LUM001 With a Double-Blind, Placebo Controlled, Randomized Drug Withdrawal Period to Evaluate...
Alagille Syndrome. Syndrome. Substance Withdrawal Syndrome. Disease. Pathologic Processes. Cholestasis, Intrahepatic. ... Randomized Drug Withdrawal Period to Evaluate Safety and Efficacy in Children With Alagille Syndrome (ICONIC). The safety and ... Genetics Home Reference related topics: Alagille syndrome Genetic and Rare Diseases Information Center resources: Alagille ... This is a long-term, open-label study with a double-blind, placebo-controlled, randomized drug withdrawal period in children ...
  https://clinicaltrials.gov/ct2/show?cond=%22Alagille+syndrome%22&rank=2
*  Vistaject-50 - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol | RxWiki
Substance Withdrawal Syndrome. *Vomiting. How long have you been taking it?. Choose one ...
  http://www.rxwiki.com/vistaject-50
*  Duraclon - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol | RxWiki
Substance Withdrawal Syndrome. *Tourette Syndrome. How long have you been taking it?. Choose one ...
  http://www.rxwiki.com/duraclon
*  N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide Summary Report | CureHunter
Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/01/2012 - "Also in humans, XBD173 displays antipanic activity and does ... did not cause sedation or withdrawal symptoms. ". 08/31/2009 - "In the withdrawal experiment, mice were orally treated with ... 08/31/2009 - "In the withdrawal experiment, mice were orally treated with either AC-5216 (0.1, 1 or 10 mg/kg; twice daily) or ... 08/31/2009 - "Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ...
  http://www.curehunter.com/public/keywordSummaryC502525-N-benzyl-N-ethyl-2--7-8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl-acetamide.do
*  Cotinine Summary Report | CureHunter
Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/01/1998 - "More specifically, this study examined the effects of ... withdrawal symptoms and adverse events. ". 01/01/1998 - "Cotinine alone had no effect on withdrawal symptoms. ". 08/01/1997 - " ... "All subjects were given placebo on the final 3 days to examine cotinine withdrawal symptoms. ". 11/01/1995 - "A dose-response ... which produced a higher percentage of cotinine replacement and better withdrawal symptom relief. ". ...
  http://www.curehunter.com/public/keywordSummaryD003367-Cotinine.do